Jazz Hits Roxane With Patent Suit Over Xyrem
Roxane Laboratories Inc. infringed the lone patent-in-suit when it submitted an application to the U.S. Food and Drug Administration seeking a green light to make, sell or import generic Xyrem, the complaint says. Jazz already has litigation pending against Roxane over Xyrem in the same court over different patents.
Jazz filed suit to...
To view the full article, register now.